COMP <GO>
TCMD vs UNH // NET PROFIT MARGIN
Tactile Systems Technology Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TCMD 8
— UNH 5
▲ NET PROFIT MARGIN LEADER: TCMD
LAST: $22.87 (-0.74%) • MKT CAP: $518.1M
net-margins
5.80%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
net-margins
3.53%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TCMD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TCMD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.90% | 88.31% | -12.41 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | 12.38% | +4.72 | TCMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 15.3x | -0.37 | TCMD | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | 6.25% | +1.09 | TCMD | /fcf-yield <GO> |
| Operating Margin | 8.90% | 5.32% | +3.58 | TCMD | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 5.80% | 3.53% | +2.27 | TCMD | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 3.33% | +9.17 | TCMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.38 | 3.09 | +5.29 | TCMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TCMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 55.1 | -7.40 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | 17.7x | +6.56 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $518.1M | $359.43B | -$358.91B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TCMD REV | UNH REV | TCMD GROSS % | UNH GROSS % | TCMD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $329.5M | $447.57B | 75.9% | 88.7% | $40.4M | $16.07B |
| FY 2024 | $293.0M | $400.28B | 74.0% | 88.3% | $38.3M | $20.70B |
| FY 2023 | $274.4M | $371.62B | — | 89.6% | $35.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TCMD // BETA —
UNH // BETA 0.33